Recent Patents on CNS Drug Discovery (Discontinued)
Title:Meet Our Editor:
Volume: 10 Issue: 1
Author(s): Vincenzo Di Marzo
Affiliation:
Export Options
About this article
Cite this article as:
Di Marzo Vincenzo, Meet Our Editor:, Recent Patents on CNS Drug Discovery (Discontinued) 2015; 10 (1) . https://dx.doi.org/10.2174/157488981001150727102300
DOI https://dx.doi.org/10.2174/157488981001150727102300 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
18
Related Articles
-
Cannabinoid Receptor G Protein-Coupling and Inverse Agonism
Current Neuropharmacology Elevated Aβ42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis
Current Alzheimer Research Hypersensitivity Reactions to Complementary and Alternative Medicine Products
Current Pharmaceutical Design Current Experimental Therapy for Alzheimers Disease
Current Neuropharmacology Correlates of Physical Activity of Children and Adolescents with Visual Impairments: A Systematic Review
Current Pharmaceutical Design Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)]
CNS & Neurological Disorders - Drug Targets Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry Depression in Older Persons with Mobility Limitations
Current Pharmaceutical Design Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Current Alzheimer Research Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases
Current Drug Targets Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
Current Neuropharmacology Caffeic Acid Phenethyl Ester Effects: In Silico Study of its Osteoimmunological Mechanisms
Letters in Drug Design & Discovery Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics
Current Pharmaceutical Design Purinergic Signaling and Hippocampal Long-Term Potentiation
Current Neuropharmacology β-Sheet Breakers for Alzheimers Disease Therapy
Current Drug Targets Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia
Central Nervous System Agents in Medicinal Chemistry Monitoring the Inflammatory Process by Surface Enhanced Nanoimaging Microscopy
Current Neurovascular Research Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons from Lithium
Current Alzheimer Research